Bausch + Lomb is up 8.2%, or $1.60 to $21.07.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLCO:
- Bausch + Lomb announces FDA approval of enVista Envy
- TPG, Blackstone teaming for Bausch + Lomb bid, may be up to $25/share, FT says
- Bausch + Lomb price target raised to $19 from $17 at Evercore ISI
- Bausch + Lomb Unveils New E-Commerce Platform, Opal
- Bausch + Lomb price target raised to $22 from $19 at H.C. Wainwright